Chile vs Russian Federation: Enforcing contracts: Quality of the judicial processes index (0-19)
Chile
55.56
in 2019
Russian Federation
52.78
in 2019
Chile rank
61st
Russian Federation rank
63rd
Enforcing contracts: Quality of the judicial processes index (0-19) over time
- Chile
- Russian Federation
How they compare
Chile currently reports 55.56 against 52.78 in Russian Federation, a difference of 2.78.
That makes Chile's figure about 1.1 times Russian Federation's.
The two have swapped places 1 time across 5 shared years of data; in 2015 it was Russian Federation ahead.
Chile ranks 61st and Russian Federation ranks 63rd of 191 countries.
Russian Federation has averaged higher in every one of the 1 decades both report.
Frequently asked questions
- Which has higher enforcing contracts: quality of the judicial processes index (0-19), Chile or Russian Federation?
- Chile, at 55.56 against 52.78 in Russian Federation as of 2019.
- What is the difference in enforcing contracts: quality of the judicial processes index (0-19) between Chile and Russian Federation?
- 2.78, with Chile ahead.
- How many years of comparable data are there for Chile and Russian Federation?
- 5 years are reported by both, from 2015 to 2019.
- How do Chile and Russian Federation rank globally for enforcing contracts: quality of the judicial processes index (0-19)?
- Chile ranks 61st and Russian Federation ranks 63rd of 191 countries.
- Where does this data come from?
- The World Bank, published as Enforcing contracts: Quality of the judicial processes index (0-19) (DB17-20 methodology) - Score. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
The score for quality of judicial processes index benchmarks economies with respect to the regulatory best practice on the indicator. The score is indicated on a scale from 0 to 100, where 0 represents the worst regulatory performance and 100 the best regulatory performance, and is computed based on the methodology in the DB17-20 studies.